US President Donald Trump and Republican US Senate reelection candidate Roger Marshall (R-KS) greet each other during a rally in Park City, Kansas, US, October 19, 2026. REUTERS/Jonathan Ernst
On Tuesday, new reporting revealed that congressional Republicans are considering the recently defeated Sen. Roger Marshall (R-KS) as a nominee to helm the Food and Drug Administration. Republicans are frantic to confirm last-minute nominees before Democrats take the majority in January, and are hoping Marshall can secure a quick approval, as current nominee Heidi Overton has struggled to make it through the Senate confirmation process due to opposition from GOP moderates.
“Marshall is viewed as an alternative if Heidi can’t make it through,” a Trump administration official told Semafor. “Senators have an easier time getting confirmed, traditionally. At this point, it’s hard to get anyone approved.” While the Senate Health Committee is scheduled to vote on Overton’s nomination on Wednesday, critics say she lacks the experience necessary to oversee a large organization like the FDA, and hundreds of medical providers have signed a letter urging senators to reject her confirmation out of concerns over her extreme views regarding reproductive rights. Her main qualification for being nominated in the first place appears to be due to her involvement in the MAGA think tank America First Policy Institute.
The GOP’s potential replacement for her, however, is also firmly in the MAGA camp. Marshall — a doctor who served two terms in the House before his Senate election in 2020 — just lost his reelection bid in Kansas to Democrat Adam Hamilton, giving the state its first blue senator in nearly 100 years. Marshall has long been considered a staunch ally of President Donald Trump and his policy agenda, and ran — then lost — under the president’s endorsement.
According to a senior Republican aide, “There is a growing view in the Senate that a senator would be the only person while we’ve got a majority so Roger Marshall’s name is quickly percolating as a person who would be confirmable.” But besides losing his Senate race by a six-point margin — a blowout considering Kansas’s deep red track record — Marshall’s controversial history regarding his medical practice could prompt opposition to his confirmation. One of the key reasons he lost his midterm race involved revelations that while practicing as an obstetrician, he had sued over 700 patients for unpaid, sometimes low-dollar medical bills, charging as much as 18 percent on late payments, with some lawsuits landing patients in jail. Despite such election-losing scandals, the GOP seems to think he’s the party’s best hope of squeaking out a final hour confirmation.
“The FDA has operated under acting leadership since former Commissioner Marty Makary was pushed out in May after clashing with the White House over whether to authorize flavored vapes,” explains Semafor. “He also faced pressure from anti-abortion Republicans who are pushing for restrictions on abortion pill mifepristone. Kyle Diamantas, a lawyer who worked as the agency’s top food official, was tapped as acting FDA commissioner and earned a reputation as a competent leader who helped stabilize the agency. But the Trump administration official said Diamantas — who did not want the top job on a permanent basis — is eyeing a departure from FDA regardless of what happens with Overton’s nomination.”
From Your Site Articles
- GOP senator dismisses deaths of 400 children from Covid ›
- The 'wow' reason a battleground GOP candidate was nearly barred from debate ›
- WSJ turns on Republican who harassed poor patients —for a different reason ›
- GOP senator humiliated in big loss to Dem pastor Adam Hamilton in Kansas ›
- Ex-GOP strategist calls Republican senator 'a living nightmare' ›
Related Articles Around the Web
